ICM-203

ICM-203 · ICM Biotech Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ICM-203, covering 2025-05-01 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis. [Phase 1, Phase 2]

See pricing